Characteristics of women exposed to nonselective COX inhibitors or COX-2 selective inhibitors, and unexposed women*.
| Variable | Exposed to Nonselective COX Inhibitors, n = 5153 | Exposed to COX-2 Selective Inhibitors, n = 114 | Unexposed, n = 105,537 |
|---|---|---|---|
| Age, yrs, mean ± SD | 30.10 ± 6.22 (p < 0.001) | 32.66 ± 6.23 (p < 0.001) | 28.53 ± 5.95 |
| Pregestational diabetes mellitus, n; % | 120; 2.3 (p < 0.001) | 3; 0.3 (p = 0.083) | 944; 0.9 |
| Inflammatory disease, n % | 5; 0.1 (p = 0.620) | 3; 2.6 (p < 0.001) | 87; 0.1 |
| Parity, mean ± SD | 1.30 ± 2.99 (p < 0.001) | 4.37 ± 2.85 (p = 0.005) | 3.68 ± 2.61 |
| Ethnic group**, n; % | |||
| Bedouin | 3388; 65.8 | 48; 42.1 | 67,707; 64.2 |
| Jewish | 1749; 34.2 (p = 0.019) | 66; 57.9 (p < 0.001) | 37,714; 35.8 |